ENTRY       D06718            Crude     Drug
NAME        Red ginseng (JP18);
            Powdered red ginseng (Non-JPS);
            Red Ginseng (TN)
COMPONENT   Ginsenoside [CPD:C08944 C08945], Acetylene derivative, Sesquiterpene, Lignan, Peptide glucan, Choline [CPD:C00114], beta-Elemene [CPD:C17094], Panaxynol [CPD:C17447]
SOURCE      Panax ginseng [TAX:4054]
REMARK      Therapeutic category: 5100
            Product: D06718<JP>
EFFICACY    Analeptic, Hypoglycemic, Sedative
COMMENT     Araliaceae (ginseng family) Panax ginseng root (steamed, dried)
            Major component: Ginsenoside [CPD:C08944 C08945]
            Powdered product: Standards for non-pharmacopoeial crude drugs
BRITE       Therapeutic category of drugs in Japan [BR:br08301]
             5  Crude drugs and Chinese medicine formulations
              51  Crude drugs
               510  Crude drugs
                5100  Crude drugs
                 D06718  Red ginseng (JP18)
            Classification of Japanese OTC drugs [BR:br08313]
             Nourishing tonics and health supplements
              46 Crude drugs
               D06718  Red ginseng (JP18)
            Risk category of Japanese OTC drugs [BR:br08312]
             Third-class OTC drugs
              Crude drugs
               Red ginseng
                D06718  Red ginseng (JP18)
            Crude drugs [BR:br08305]
             Dicot plants: asterids
              Araliaceae (ginseng family)
               D06718  Red ginseng
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Crude drugs
              D06718  Red ginseng
             Crude drugs (non-JPS)
              D06718  Powdered red ginseng
DBLINKS     PubChem: 47208369
///
